Skip to content

Vitamin D and T-Regulatory Cells in Coronary Artery Disease

Vitamin D and T-Regulatory Cells in Coronary Artery Disease

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01183962
Enrollment
50
Registered
2010-08-18
Start date
2010-02-28
Completion date
Unknown
Last updated
2011-08-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary Artery Disease, Cardiovascular Disease

Keywords

CAD, Vitamin D, CVD

Brief summary

The purpose of this study is to evaluate the effect of Vitamin D supplementation on cardiovascular disease and certain cells (T-regulatory cells) in the body that play a role in plaque formation in arteries. This study will determine the levels of Vitamin D and T-regulatory cells in subjects with coronary artery disease and if Vitamin D supplementation will affect future events such as heart attach and stroke.

Interventions

DIETARY_SUPPLEMENTVitamin D

Vitamin D 3000 IU daily

No intervention

Sponsors

Creighton University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
30 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* between the ages of 30 and 80 years * have a history of medically treated coronary artery disease

Exclusion criteria

* history of smoking in the past 2 years * history of diabetes mellitus

Design outcomes

Primary

MeasureTime frameDescription
increase in T-regulatory Cells1 yearWe expect significant improvement in the suppressive capacity, with or without increase in the number, of circulating T-regs after vitamin D supplementation. This increase in T-regs function will correlate with improvement in clinical parameters.

Secondary

MeasureTime frameDescription
decrease pro-inflammatory cytokines & sTNFR1 and increase serum IL-101 yearWe also expect that vitamin D supplementation will decrease the levels of pro-inflammatory cytokines and sTNFR1 and increase the level of serum IL-10

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026